Hokkaido University – BioJapan 2026
2026.09.30
Hokkaido University will participate in BioJapan 2026, one of Asia’s leading biotechnology partnering events, to be held at PACIFICO Yokohama from October 7–9, 2026.
Official website: BioJapan 2026
Representatives from Hokkaido University will present a broad portfolio of research achievements and emerging technologies in the life sciences, biotechnology, drug discovery, diagnostics, and medical technology fields.
Through BioJapan 2026, Hokkaido University seeks to further promote international research exchange and contribute to the advancement of biopharmaceutical science and innovation.
1. Neurology & Regenerative Medicine
1. GFRα1: A First-in-Class Lead for Functional CNS and PNS Nerve Regeneration
2.Peptide p3-Alcβ9-19: A Primate-Validated, Brain-Penetrant Mitochondrial Activator for AD
3. Targeted RNA Chaperones: A Precise Mechanism to Protect Motor Neurons in ALS
4. NET Inhibitors: Accelerating Acute Nerve Repair via the MIF/CXCR4 Axis
30. BDNF-Inducing Peptides: A Neuroprotective Approach for Glaucoma Treatment, Complementing IOP-lowering Therapy
2.Peptide p3-Alcβ9-19: A Primate-Validated, Brain-Penetrant Mitochondrial Activator for AD
3. Targeted RNA Chaperones: A Precise Mechanism to Protect Motor Neurons in ALS
4. NET Inhibitors: Accelerating Acute Nerve Repair via the MIF/CXCR4 Axis
30. BDNF-Inducing Peptides: A Neuroprotective Approach for Glaucoma Treatment, Complementing IOP-lowering Therapy
2. Drug Delivery, RNA & Gene Therapy
5. HSC-Targeted LNPs: A Precision Delivery Platform for Reversing Hepatic Fibrosis
6. Spleen-Specific LNPs: Optimized Dendritic Cell Delivery for Next-Gen Vaccines
7. Helper Lipids: A Potency-Boosting Solution for Enhanced Endosomal Escape
8. Novel ζ-Lipids for Cas9 RNP Delivery: 98% Gene Knockout in vivo
9. Novel Cationic Lipids for Extrahepatic Delivery
10. Long-Chain DNA LNPs: Overcoming Size Barriers in Non-Viral Gene Delivery
11. Lung-Targeted LNP Anti-Inflammatory Drug Delivery Technology Lung-Targeted LNP Anti-Inflammatory Drug Delivery Technology — Efficacy Demonstrated in Severe COVID-19 Pneumonia Models
25. srRNA: A Stable, Vector-Based Alternative for Exon-Skipping Therapies
26. MITO-Porter & CRISPR/Cas9: An Advanced Platform for Mitochondrial Gene Editing
6. Spleen-Specific LNPs: Optimized Dendritic Cell Delivery for Next-Gen Vaccines
7. Helper Lipids: A Potency-Boosting Solution for Enhanced Endosomal Escape
8. Novel ζ-Lipids for Cas9 RNP Delivery: 98% Gene Knockout in vivo
9. Novel Cationic Lipids for Extrahepatic Delivery
10. Long-Chain DNA LNPs: Overcoming Size Barriers in Non-Viral Gene Delivery
11. Lung-Targeted LNP Anti-Inflammatory Drug Delivery Technology Lung-Targeted LNP Anti-Inflammatory Drug Delivery Technology — Efficacy Demonstrated in Severe COVID-19 Pneumonia Models
25. srRNA: A Stable, Vector-Based Alternative for Exon-Skipping Therapies
26. MITO-Porter & CRISPR/Cas9: An Advanced Platform for Mitochondrial Gene Editing
3. Oncology
12. PIECE Platform Technology targeting Intracellular IL-6 for Tumor Therapeutics
13. Anti-IL-34 mAbs: Strategic Add-ons to Overcome Therapeutic Resistance
14. DCA-Micelles: A Precision Metabolic Radiosensitizer for Local Tumor Control
15. Drug Discovery Targeting the BATF3/IRF4 Axis Enabling Indication Expansion Beyond ATLL
16. A Novel Therapeutic Strategy for HCC Targeting Tumor Metabolic Transporters
17. Retinoid Pathway-Targeted Therapy for Synovial Sarcoma and Soft Tissue Sarcomas
18. Dual MCT1/MCT4 Inhibition Strategy for Hypoxia-Resistant Hepatocellular Carcinoma
20. Next-Gen STING Agonists: Converting Cold Tumors via Potent Systemic Activation
21. C16orf74 Dimer-Blockers: Targeting a Critical Malignancy Driver in Pancreatic Cancer
13. Anti-IL-34 mAbs: Strategic Add-ons to Overcome Therapeutic Resistance
14. DCA-Micelles: A Precision Metabolic Radiosensitizer for Local Tumor Control
15. Drug Discovery Targeting the BATF3/IRF4 Axis Enabling Indication Expansion Beyond ATLL
16. A Novel Therapeutic Strategy for HCC Targeting Tumor Metabolic Transporters
17. Retinoid Pathway-Targeted Therapy for Synovial Sarcoma and Soft Tissue Sarcomas
18. Dual MCT1/MCT4 Inhibition Strategy for Hypoxia-Resistant Hepatocellular Carcinoma
20. Next-Gen STING Agonists: Converting Cold Tumors via Potent Systemic Activation
21. C16orf74 Dimer-Blockers: Targeting a Critical Malignancy Driver in Pancreatic Cancer
4. Immunology, Inflammation & Other Therapeutics
19. Epigenetic Modulator for Refractory GVHD and IBD
22. STAP-1 Peptides: Selective T-Cell Modulation for Precision Autoimmune Therapy
23. Restoring NET Degradation in ANCA Vasculitis
24. Meflin: A Novel Biomarker and Therapeutic Target for Systemic Inflammation
27. IL-34-Induced Macrophages: Autologous Cell Therapy for Advanced Liver Cirrhosis
28. Resolvin E3 Indoles: A Pro-Resolving Approach for Insulin Resistance
29. Syk Inhibitors: A Safety Bridge for Post-Denosumab Transition in Osteoporosis
31. Selective Senolytics: Removing Senescent Cells to Reverse UV Induced Skin Aging
22. STAP-1 Peptides: Selective T-Cell Modulation for Precision Autoimmune Therapy
23. Restoring NET Degradation in ANCA Vasculitis
24. Meflin: A Novel Biomarker and Therapeutic Target for Systemic Inflammation
27. IL-34-Induced Macrophages: Autologous Cell Therapy for Advanced Liver Cirrhosis
28. Resolvin E3 Indoles: A Pro-Resolving Approach for Insulin Resistance
29. Syk Inhibitors: A Safety Bridge for Post-Denosumab Transition in Osteoporosis
31. Selective Senolytics: Removing Senescent Cells to Reverse UV Induced Skin Aging
5. Infectious Diseases & Vaccines
32. Neutralizing mAbs for Marburg Virus: High-Potency Outbreak Control Tools
33. Universal Pan-Species Ebola Antibodies: A Cross-Neutralizing Therapeutic Lead
34. Nemuri-Derived Peptides: A New Line of Defense Against MDR Bacterial Pathogens
35. Rapid Production of Next-Generation Vaccine Particles Using Microfluidic Technology
36. 2-thiouridine (s2U): A Broad-Spectrum Antiviral for Positive-Strand RNA Viruses
33. Universal Pan-Species Ebola Antibodies: A Cross-Neutralizing Therapeutic Lead
34. Nemuri-Derived Peptides: A New Line of Defense Against MDR Bacterial Pathogens
35. Rapid Production of Next-Generation Vaccine Particles Using Microfluidic Technology
36. 2-thiouridine (s2U): A Broad-Spectrum Antiviral for Positive-Strand RNA Viruses
6. Diagnostics, Research Technologies & Medical Devices
37. Bioluminescent BLI Mice: Real-Time evaluation for Reproductive Toxicity
38. Enhanced Mammalian Cell Vectors: High-Yield Production of Bio-Active Proteins
39. IgA N-Glycan Markers: A Non-Invasive Diagnostic Tool for MASH Fibrosis Stages
40. HD5 Diagnostic Kits: Precision Monitoring for Intestinal Health and Microbiome
41. Micro-Scale SAR Platform: Rapid Structure-Optimization for Peptide Leads
42. Nonribosomal Peptide Cyclases: A High-Throughput Engine for Cyclic Peptide Discovery
43. Portable Parasite NGS: A Field-Ready Comprehensive Detection System
44. Ultra-Sensitive Immunoassay Platform Using Advanced Optical Sensing
45. AI-Ultrasound Software: Automated Diagnostic Inference for Pediatric Hip Health
46. Standardized Exosome-like Particles: Consistent Controls for Liquid Biopsies
47. Attachment for Microscope Objective Lenses and Microscope
48. Non-Invasive taVNS Device: A Neuromodulation Strategy for Interstitial Pneumonia
49. Biomimetic Artificial Cartilage Implant for Durable Joint Repair
50. Cation-π Polymer Embolic Agent: Safe, Injectable, and Stable Vessel Occlusion
38. Enhanced Mammalian Cell Vectors: High-Yield Production of Bio-Active Proteins
39. IgA N-Glycan Markers: A Non-Invasive Diagnostic Tool for MASH Fibrosis Stages
40. HD5 Diagnostic Kits: Precision Monitoring for Intestinal Health and Microbiome
41. Micro-Scale SAR Platform: Rapid Structure-Optimization for Peptide Leads
42. Nonribosomal Peptide Cyclases: A High-Throughput Engine for Cyclic Peptide Discovery
43. Portable Parasite NGS: A Field-Ready Comprehensive Detection System
44. Ultra-Sensitive Immunoassay Platform Using Advanced Optical Sensing
45. AI-Ultrasound Software: Automated Diagnostic Inference for Pediatric Hip Health
46. Standardized Exosome-like Particles: Consistent Controls for Liquid Biopsies
47. Attachment for Microscope Objective Lenses and Microscope
48. Non-Invasive taVNS Device: A Neuromodulation Strategy for Interstitial Pneumonia
49. Biomimetic Artificial Cartilage Implant for Durable Joint Repair
50. Cation-π Polymer Embolic Agent: Safe, Injectable, and Stable Vessel Occlusion